Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.4K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.6K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.6K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

1.4K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.4K
Chemical Synapses01:26

Chemical Synapses

10.5K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
10.5K
Chemical Synapses01:26

Chemical Synapses

3.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
3.8K
Muscle Contraction01:10

Muscle Contraction

8.2K
In skeletal muscles, acetylcholine is released by nerve terminals at the motor endplate—the point of synaptic communication between motor neurons and muscle fibers. The binding of acetylcholine to its receptors on the sarcolemma allows entry of sodium ions into the cell and triggers an action potential in the muscle cell. Thus, electrical signals from the brain are transmitted to the muscle. Subsequently, the enzyme acetylcholinesterase breaks down acetylcholine to prevent excessive...
8.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Limb Girdle Muscular Dystrophy Associated With TRIM32 Variants: A National Cohort Study.

Muscle & nerve·2026
Same author

Engineering SIRPα conformational plasticity to reveal a cryptic pocket suitable for structure-based drug design.

bioRxiv : the preprint server for biology·2026
Same author

How closely do ecosystem services and life cycle assessment frameworks concur when evaluating contrasting animal-production systems with ruminant or monogastric species?

Animal : an international journal of animal bioscience·2024
Same author

Guillain-Barré syndrome following subthalamic nucleus - Deep Brain Stimulation in Parkinson's disease: A case report.

Revue neurologique·2023
Same author

Current clinical management of CIDP with immunoglobulins in France: An expert opinion.

Revue neurologique·2023
Same author

Heat Equilibration of Integer and Fractional Quantum Hall Edge Modes in Graphene.

Physical review letters·2022

Related Experiment Video

Updated: Nov 15, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.6K

Myasthenia gravis and pregnancy.

P Roche1, F Bouhour1

  • 1Service d'électroneuromyographie et pathologies neuromusculaires - Hôpital Pierre-Wertheimer - CHU de Lyon HCL - GH Est, 59, boulevard Pinel, Bron cedex, Lyon, France.

Revue Neurologique
|March 2, 2021
PubMed
Summary

Planning pregnancy is crucial for women with myasthenia gravis to minimize risks to both mother and baby. Careful management and multidisciplinary follow-up are essential during pregnancy and postpartum.

Keywords:
Myasthenia gravisPathophysiologyPregnancyTreatment

More Related Videos

Measuring Neuromuscular Junction Functionality
10:40

Measuring Neuromuscular Junction Functionality

Published on: August 6, 2017

18.4K
Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models
04:30

Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models

Published on: March 8, 2024

1.2K

Related Experiment Videos

Last Updated: Nov 15, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.6K
Measuring Neuromuscular Junction Functionality
10:40

Measuring Neuromuscular Junction Functionality

Published on: August 6, 2017

18.4K
Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models
04:30

Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models

Published on: March 8, 2024

1.2K

Area of Science:

  • Neurology
  • Autoimmune Diseases
  • Reproductive Health

Background:

  • Myasthenia gravis is an autoimmune disorder causing fluctuating muscle weakness, particularly affecting the girdles, axial, and bulbar muscles.
  • It is more prevalent in women, often manifesting in their second or third decade, leading to an increasing number of pregnancies in affected individuals.

Purpose of the Study:

  • To highlight the importance of pregnancy planning for women with myasthenia gravis.
  • To emphasize the need for multidisciplinary management and treatment review during pregnancy to mitigate risks.

Main Methods:

  • Review of existing literature and clinical guidelines concerning myasthenia gravis and pregnancy.
  • Discussion of teratogenic risks associated with specific medications and the benefits of multidisciplinary care.

Main Results:

  • Pregnancy planning is vital to minimize maternal and neonatal complications.
  • Treatment regimens require careful review due to potential teratogenic effects of certain drugs (e.g., mycophenolate mofetil, rituximab).

Conclusions:

  • Proactive pregnancy planning is essential for women with myasthenia gravis.
  • Multidisciplinary follow-up and adjusted treatment strategies are critical for successful pregnancy outcomes and preventing postpartum myasthenic crisis.